H.B. Fuller Makes Recommended Cash Offer To Acquire Advanced Medical Solutions At £2.85 Per Share, Implying £715M Enterprise Value, Expects ~$55M In Run-Rate Synergies
H.B. Fuller Company
H.B. Fuller Company FUL | 0.00 |
- Extends capabilities in attractive, high-growth medical segments
- Accelerates portfolio mix shift and path to >20% EBITDA margin target
- Expected to deliver ~$55 million in run-rate synergies
